SCHEMBL7760979

SCHEMBL7760979

[CH2]CCC(O)C(C)Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.65
CYP2D6 P10635 1/20 0.50
TAAR1 Q96RJ0 4/20 0.44
SIGMAR1 Q99720 4/20 0.44
SLC6A2 P23975 2/20 0.44
MAOA P21397 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CYP2A6 P11509 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
CSNK1E P49674 1/20 0.41
SLC18A2 Q05940 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LAP3 P28838 3/20 0.40
ANPEP P15144 1/20 0.40
RNPEP Q9H4A4 1/20 0.40
DNPEP Q9ULA0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19707045 0.83 TRPA1 (0.72) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL11613701 0.80 TRPA1 (0.68) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL12768230 0.79 TRPA1 (1.00) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL18456337 0.79 TRPA1 (1.00) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL16169480 0.79 TRPA1 (0.71) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL19725385 0.78 TRPA1 (0.69) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL234669 0.78 TRPA1 (0.69) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL21852752 0.78 TRPA1 (0.69) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL2600699 0.77 TRPA1 (0.69) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2
SCHEMBL2600697 0.77 TRPA1 (0.69) TRPA1CYP2D6TAAR1SIGMAR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1090908-A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase ABBOTT LABORATORIES (US) 2001-04-11 EP claimed
US-5831115-A CYCLOBUTANECARBOXAMIDES ABBOTT LABORATORIES (US) 1998-11-03 US claimed
EP-0821665-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE Abbott Laboratories (US) 1998-02-04 EP claimed
WO-1996033159-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE ABBOTT LABORATORIES (US) 1996-10-24 WO claimed
EP-1090908-A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase ABBOTT LABORATORIES (US) 2001-04-11 EP disclosed
US-5831115-A CYCLOBUTANECARBOXAMIDES ABBOTT LABORATORIES (US) 1998-11-03 US disclosed
EP-0821665-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE Abbott Laboratories (US) 1998-02-04 EP disclosed
WO-1996033159-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE ABBOTT LABORATORIES (US) 1996-10-24 WO disclosed